Impact of histamine and histamine2 receptor antagonists on quality of life and antitumour responses: Results of a pilot trial [3]

S. Milanese; L. A. Hansen; C. E. Desch; C. Honeycutt; F. Tesfaye; T. J. Smith

doi:10.1016/S0959-8049(97)00330-4

Impact of histamine and histamine₂ receptor antagonists on quality of life and antitumour responses: Results of a pilot trial [3]

S. Milanese, L. A. Hansen, C. E. Desch, C. Honeycutt, F. Tesfaye, T. J. Smith

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	2436-2437
Number of pages	2
Journal	European Journal of Cancer
Volume	33
Issue number	14
DOIs	https://doi.org/10.1016/S0959-8049(97)00330-4
State	Published - 1997
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/S0959-8049(97)00330-4

Cite this

@article{fb16c482deb54f07bb01ef6603097f63,

title = "Impact of histamine and histamine2 receptor antagonists on quality of life and antitumour responses: Results of a pilot trial [3]",

author = "S. Milanese and Hansen, {L. A.} and Desch, {C. E.} and C. Honeycutt and F. Tesfaye and Smith, {T. J.}",

note = "Funding Information: Acknowledgements—Supported in part by an unrestricted grant from Glaxo, Inc., Research Triangle Park, NC, a grant from the Agency for Health Care Policy and Research (RO1 HS 07614) (TJS), a grant from the OYce of Cancer Communications, National Cancer Institute (RFP CO 94388-63) (TJS), a Career Development Award from the American Cancer Society, Atlanta, Georgia (TJS), and a Faculty Scholar Award, Project on Death in America, Open Society, New York (TJS).",

year = "1997",

doi = "10.1016/S0959-8049(97)00330-4",

language = "English (US)",

volume = "33",

pages = "2436--2437",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

number = "14",

}

TY - JOUR

T1 - Impact of histamine and histamine2 receptor antagonists on quality of life and antitumour responses

T2 - Results of a pilot trial [3]

AU - Milanese, S.

AU - Hansen, L. A.

AU - Desch, C. E.

AU - Honeycutt, C.

AU - Tesfaye, F.

AU - Smith, T. J.

N1 - Funding Information: Acknowledgements—Supported in part by an unrestricted grant from Glaxo, Inc., Research Triangle Park, NC, a grant from the Agency for Health Care Policy and Research (RO1 HS 07614) (TJS), a grant from the OYce of Cancer Communications, National Cancer Institute (RFP CO 94388-63) (TJS), a Career Development Award from the American Cancer Society, Atlanta, Georgia (TJS), and a Faculty Scholar Award, Project on Death in America, Open Society, New York (TJS).

PY - 1997

Y1 - 1997

UR - http://www.scopus.com/inward/record.url?scp=0031283499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031283499&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(97)00330-4

DO - 10.1016/S0959-8049(97)00330-4

M3 - Article

C2 - 9616297

AN - SCOPUS:0031283499

SN - 0959-8049

VL - 33

SP - 2436

EP - 2437

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 14

ER -

Impact of histamine and histamine2 receptor antagonists on quality of life and antitumour responses: Results of a pilot trial [3]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

Impact of histamine and histamine₂ receptor antagonists on quality of life and antitumour responses: Results of a pilot trial [3]